Gros David-Alexandre C Insider Trades

Insider Trading History

Track insider trading activity for Gros David-Alexandre C. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $2.16M 600,000 shares
Last Trade
Jan 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.42M 600,000 shares
$4.04
$3.60
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $3.66M 1,015,743 shares
Last Trade
Nov 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.13M 1,015,743 shares
$4.07
$3.60
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $1.86M 517,454 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.52M 517,454 shares
$2.94
$3.60
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $1.38M 383,299 shares
Last Trade
May 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$882k 383,299 shares
$2.30
$3.60
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $1.08M 300,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.53M 453,600 shares
$3.38
$3.60
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $389k 108,000 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$429k 108,000 shares
$3.97
$3.60
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $32.4k 9,000 shares
Last Trade
Dec 20, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.96k 2,000 shares
$4.48
$3.60
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $25.2k 7,000 shares
Last Trade
Aug 17, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24.8k 4,000 shares
$6.21
$3.60
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $10.8k 3,000 shares
Last Trade
Jun 09, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24k 3,000 shares
$8.01
$3.60
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Chief Executive Officer
Holding Value $65.8k 18,278 shares
Last Trade
Sep 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.60
Neurocrine Biosciences
Neurocrine Biosciences NBIX
President & COO
Holding Value $4.18M 25,000 shares
Last Trade
Feb 06, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 25,000 shares
$43.24
$167.35
Neurocrine Biosciences
Neurocrine Biosciences NBIX
President & COO
Holding Value $58.6M 350,000 shares
Last Trade
Feb 01, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.9M 350,000 shares
$42.55
$167.35
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $7.59M 25,000 shares
Last Trade
Dec 20, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.06M 25,000 shares
$42.22
$303.64
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $304k 1,000 shares
Last Trade
Feb 22, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$56.5k 900 shares
$62.75
$303.64
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $30.4k 100 shares
Last Trade
Feb 22, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.27k 100 shares
$62.74
$303.64
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $4.56M 15,012 shares
Last Trade
Dec 18, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.34M 15,012 shares
$88.95
$303.64
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Svp, Chief Business Officer
Holding Value $42.5M 140,000 shares
Last Trade
Jun 08, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.2M 140,000 shares
$129.97
$303.64

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up